Physician
SSM Health Care of Wisconsin, INC.
SSM Health Care of Wisconsin, INC. was paid $14.70M by Medicaid between Jan 2018 and Dec 2024, across 235 billing codes. Its largest line is 99284, emergency room visit (serious) — 14% of everything it billed.
33Billing provider infoSSM HEALTH CARE OF WISCONSIN, INC.
MADISON, WI 53715
MADISON, WI 53715
33aNPI1184621211assigned 07/05/2005
33bProvider typeInternal Medicine Physician
28Total paid$14.70M
24GClaims680,502
24DCodes billed235
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Wisconsin
Rank by total paid#2 of 160
Median peer was paid$6K
This provider vs. median2,463×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 92,985 | $2.44M | |
| 2019 | 100,284 | $2.34M | |
| 2020 | 89,595 | $1.99M | |
| 2021 | 110,227 | $2.17M | |
| 2022 | 110,370 | $2.13M | |
| 2023 | 102,868 | $2.05M | |
| 2024incomplete | 74,173 | $1.59M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 36,539 | 31,331 | $2.05M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 28,642 | 25,605 | $1.99M |
| 96361 | Intravenous infusion, hydration; each additional hour | 12% | 14,795 | 11,884 | $1.71M |
| 80053 | Comprehensive metabolic panel | 4.7% | 27,195 | 22,489 | $685K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.4% | 9,396 | 7,979 | $494K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.8% | 6,187 | 5,469 | $409K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.6% | 5,121 | 4,574 | $388K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.5% | 4,448 | 4,124 | $362K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.1% | 4,919 | 4,383 | $307K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.0% | 13,783 | 11,065 | $294K |
| 59025 | Fetal non-stress test | 1.9% | 3,654 | 2,570 | $282K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.8% | 5,132 | 3,960 | $260K |
223 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.7% | 3,130 | $248K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 4,208 | $239K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.5% | 704 | $221K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 5,884 | $217K |
| 76801 | 1.4% | 3,230 | $199K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.3% | 2,532 | $193K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 31,662 | $187K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.2% | 2,709 | $171K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 3,446 | $157K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.0% | 1,500 | $149K |
| G0378 | Hospital observation service, per hour | <1% | 5,469 | $143K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,755 | $142K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,880 | $125K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,571 | $116K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,307 | $109K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 2,155 | $108K |
| 81025 | <1% | 10,688 | $106K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,046 | $101K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 2,763 | $101K |
| 84484 | <1% | 12,559 | $101K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,079 | $96K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,317 | $94K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,729 | $84K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,540 | $75K |
| 82962 | <1% | 12,696 | $74K | |
| 83880 | <1% | 3,245 | $68K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 820 | $65K |
| 83605 | <1% | 8,339 | $62K | |
| 80306 | <1% | 3,952 | $61K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 624 | $60K |
| 81001 | <1% | 11,898 | $58K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,559 | $57K |
| 93975 | <1% | 1,202 | $56K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,666 | $55K |
| 93296 | <1% | 2,428 | $51K | |
| 83690 | <1% | 9,636 | $50K | |
| 84702 | <1% | 1,432 | $49K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,485 | $47K |
| 87808 | <1% | 2,550 | $44K | |
| 82077 | <1% | 4,511 | $44K | |
| 85027 | <1% | 8,218 | $42K | |
| 76813 | <1% | 2,027 | $42K | |
| 80143 | <1% | 2,601 | $41K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 800 | $40K |
| 81003 | <1% | 6,814 | $35K | |
| 87205 | <1% | 3,955 | $35K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,080 | $33K |
| 82805 | <1% | 1,156 | $30K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 411 | $27K |
| 86850 | <1% | 3,627 | $26K | |
| 84145 | <1% | 1,705 | $26K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 668 | $26K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 409 | $24K |
| 80179 | <1% | 2,492 | $24K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 567 | $23K |
| 87081 | <1% | 1,280 | $23K | |
| 83735 | <1% | 5,057 | $22K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 454 | $22K |
| 87077 | <1% | 2,409 | $22K | |
| 87040 | <1% | 3,033 | $21K | |
| 93458 | <1% | 62 | $20K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,316 | $20K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 1,044 | $20K |
| 12001 | <1% | 220 | $19K | |
| 87486 | <1% | 394 | $18K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 172 | $17K |
| 70498 | <1% | 192 | $17K | |
| 85379 | <1% | 2,098 | $16K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,094 | $16K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 816 | $15K |
| 87186 | <1% | 1,997 | $15K | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 469 | $15K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 620 | $14K |
| 70496 | <1% | 145 | $13K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 22,521 | $12K |
| 93971 | <1% | 322 | $12K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,664 | $12K |
| 87631 | <1% | 78 | $12K | |
| 85610 | <1% | 4,533 | $12K | |
| 87581 | <1% | 394 | $11K | |
| 76830 | Ultrasound, transvaginal | <1% | 345 | $11K |
| 80050 | General health panel | <1% | 1,760 | $10K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,912 | $9K |
| 80061 | Lipid panel | <1% | 1,409 | $9K |
| 86900 | <1% | 3,719 | $9K | |
| 87070 | <1% | 866 | $9K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 4,363 | $9K |
| 86901 | <1% | 3,752 | $9K | |
| 78431 | <1% | 46 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,912 | $7K |
| 84703 | <1% | 722 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 16,907 | $6K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 395 | $5K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 13 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 343 | $5K |
| 12011 | <1% | 46 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 11,460 | $5K |
| 87653 | <1% | 114 | $5K | |
| 97162 | <1% | 193 | $5K | |
| 70486 | <1% | 175 | $5K | |
| 90715 | <1% | 552 | $4K | |
| 86140 | <1% | 1,019 | $3K | |
| 12002 | <1% | 39 | $3K | |
| 76820 | <1% | 43 | $2K | |
| 29125 | <1% | 52 | $2K | |
| 85730 | <1% | 436 | $2K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 157 | $2K |
| 93798 | <1% | 72 | $2K | |
| 80047 | <1% | 46 | $2K | |
| 64400 | <1% | 13 | $2K | |
| 96367 | <1% | 38 | $2K | |
| 84112 | <1% | 19 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,497 | $2K |
| 80305 | <1% | 35 | $2K | |
| 93325 | <1% | 71 | $1K | |
| 93017 | <1% | 56 | $1K | |
| 88342 | <1% | 1,113 | $1K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 40 | $1K |
| 97166 | <1% | 41 | $1K | |
| 51798 | <1% | 695 | $1K | |
| 82550 | <1% | 214 | $1K | |
| P9045 | Infusion, albumin (human), 5%, 250 ml | <1% | 17 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,056 | $1K |
| 10060 | <1% | 16 | $987.53 | |
| 73030 | <1% | 616 | $905.14 | |
| 82570 | <1% | 306 | $900.46 | |
| 86803 | <1% | 18 | $890.80 | |
| 97161 | <1% | 13 | $630.87 | |
| 73610 | <1% | 925 | $591.85 | |
| 85014 | <1% | 361 | $566.79 | |
| 87075 | <1% | 113 | $521.90 | |
| 72100 | <1% | 271 | $478.13 | |
| 73562 | <1% | 1,131 | $463.65 | |
| 88307 | <1% | 240 | $449.22 | |
| 82565 | <1% | 16 | $373.80 | |
| 97116 | <1% | 17 | $346.39 | |
| 76937 | <1% | 44 | $343.08 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 25,912 | $338.87 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 9,837 | $314.09 |
| 85018 | <1% | 186 | $292.58 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 628 | $259.18 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 3,124 | $250.68 |
| 85652 | <1% | 134 | $230.67 | |
| 84100 | <1% | 67 | $230.37 | |
| 96376 | <1% | 3,803 | $205.66 | |
| 87340 | <1% | 29 | $194.13 | |
| 93298 | <1% | 16 | $187.20 | |
| 73630 | <1% | 812 | $186.28 | |
| 99292 | <1% | 19 | $168.98 | |
| J2704 | Injection, propofol, 10 mg | <1% | 6,517 | $166.60 |
| 72170 | <1% | 298 | $147.70 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,109 | $145.04 |
| 84156 | <1% | 46 | $140.96 | |
| 87147 | <1% | 26 | $131.47 | |
| 86780 | <1% | 13 | $114.16 | |
| 84466 | <1% | 41 | $94.38 | |
| 84439 | <1% | 20 | $93.20 | |
| 73130 | <1% | 679 | $83.61 | |
| 74018 | <1% | 98 | $82.98 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 11,523 | $74.23 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 10,472 | $73.33 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 7,875 | $69.07 |
| 86592 | <1% | 16 | $61.74 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 30 | $60.19 |
| 83540 | <1% | 42 | $49.17 | |
| 73110 | <1% | 275 | $46.54 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 13,932 | $44.62 |
| 0352U | <1% | 155 | $30.42 | |
| 82607 | <1% | 12 | $21.62 | |
| 82272 | <1% | 12 | $21.30 | |
| 85007 | <1% | 33 | $18.90 | |
| 73502 | <1% | 25 | $18.47 | |
| 88304 | <1% | 66 | $17.54 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,688 | $15.33 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,765 | $15.26 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 5,113 | $13.99 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,931 | $13.46 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 7,880 | $13.12 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 6,190 | $12.38 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,117 | $12.22 |
| 82043 | <1% | 16 | $11.60 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,381 | $11.35 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,184 | $7.09 |
| C1769 | Guide wire | <1% | 919 | $3.30 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 64 | $3.06 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 2,066 | $1.44 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 654 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 1,231 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 523 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 450 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 94 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 32 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 316 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 13 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 102 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 140 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 97 | $0.00 |
| J2720 | Injection, protamine sulfate, per 10 mg | 0% | 16 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 97 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 0% | 58 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 53 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 30 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 53 | $0.00 |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 0% | 15 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 16 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 13 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 2,467 | $0.00 |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 0% | 46 | $0.00 |
| A9270 | Non-covered item or service | 0% | 6,740 | $0.00 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 12 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 391 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 394 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 765 | $0.00 |
| 88341 | 0% | 191 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 443 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 15 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 120 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 73 | $0.00 |
| J3490 | Unclassified drugs | 0% | 71 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 44 | $0.00 |
| 74019 | 0% | 13 | $0.00 | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 0% | 13 | $0.00 |
| 71101 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMINERATH, JOSEPH (SYSTEM DIR OF GOV REIMBURSEMENT)
| Provider | Location | Paid |
|---|---|---|
| SSM Health Care of Wisconsin INC | Baraboo, WI | $9.78M |
| SSM Health Care of Wisconsin, INC. | Janesville, WI | $8.37M |
| SSM Health Care of Wisconsin, INC | Madison, WI | $6.40M |
| Ripon Medical Center INC | Ripon, WI | $4.30M |
| Agnesian Healthcare INC | Fond Du Lac, WI | $2.25M |
| SSM Health Care of Wisconsin INC | Janesville, WI | $1.03M |
| Agnesian Healthcare INC | Fond Du Lac, WI | $172K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.